* INVO Bioscience Inc INVO.OQ INVO.O is expected to show
a
fall in quarterly revenue when it reports results on April 10
(estimated).
* The Lakewood Ranch Florida-based company is expected to
report
a 91.6% decrease in revenue to $257 thousand from $3.05 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for INVO Bioscience Inc
is
for a loss of 19 cents per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for INVO
Bioscience
Inc is $2, above its last closing price of $0.58.
This summary was machine generated April 7 at 20:29 GMT. All
figures in US dollars unless otherwise stated